Yanjun Hou to Female
This is a "connection" page, showing publications Yanjun Hou has written about Female.
Connection Strength
0.745
-
Hou Y, Peng Y, Li Z. Update on prognostic and predictive biomarkers of breast cancer. Semin Diagn Pathol. 2022 Sep; 39(5):322-332.
Score: 0.059
-
Hou Y, Yang B, Zhang G. Female Adnexal Tumor of Probable Wolffian Origin. Arch Pathol Lab Med. 2022 Jan 02; 146(2):166-171.
Score: 0.057
-
Hou Y, He X, Chute DJ. Paraganglioma-like medullary thyroid carcinoma: A case report and literature review. Diagn Cytopathol. 2020 Jun; 48(6):559-563.
Score: 0.050
-
Hou Y, Bruehl FK, McHugh KE, Reynolds JP. Primary tumor types and origins in positive abdominopelvic washing cytology, a single institution experience. J Am Soc Cytopathol. 2020; 9(2):89-94.
Score: 0.049
-
Hou Y, Nitta H, Parwani AV, Li Z. PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancers. Hum Pathol. 2019 Apr; 86:108-114.
Score: 0.046
-
Hou Y, Nitta H, Wei L, Banks PM, Lustberg M, Wesolowski R, Ramaswamy B, Parwani AV, Li Z. PD-L1 expression and CD8-positive T cells are associated with favorable survival in HER2-positive invasive breast cancer. Breast J. 2018 Nov; 24(6):911-919.
Score: 0.045
-
Hou Y, Nitta H, Wei L, Banks PM, Parwani AV, Li Z. Evaluation of Immune Reaction and PD-L1 Expression Using Multiplex Immunohistochemistry in HER2-Positive Breast Cancer: The Association With Response to Anti-HER2 Neoadjuvant Therapy. Clin Breast Cancer. 2018 Apr; 18(2):e237-e244.
Score: 0.043
-
Hou Y, Nitta H, Wei L, Banks PM, Portier B, Parwani AV, Li Z. HER2 intratumoral heterogeneity is independently associated with incomplete response to anti-HER2 neoadjuvant chemotherapy in HER2-positive breast carcinoma. Breast Cancer Res Treat. 2017 Nov; 166(2):447-457.
Score: 0.042
-
Hou Y, Zynger DL, Li X, Li Z. Comparison of Oncotype DX With Modified Magee Equation Recurrence Scores in Low-Grade Invasive Carcinoma of Breast. Am J Clin Pathol. 2017 Aug 01; 148(2):167-172.
Score: 0.042
-
Hou Y, Tozbikian G, Zynger DL, Li Z. Using the Modified Magee Equation to Identify Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay (Oncotype DX Assay). Am J Clin Pathol. 2017 Jun 01; 147(6):541-548.
Score: 0.041
-
Hou Y, Shen R, Chaudhary S, Tonkovich D, Li Z. Utility of different immunostains for diagnosis of metastatic breast carcinomas in both surgical and cytological specimens. Ann Diagn Pathol. 2017 Oct; 30:21-27.
Score: 0.041
-
Hou Y, Nitta H, Li Z. HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer. Am J Clin Pathol. 2017 Jan 01; 147(1):89-95.
Score: 0.040
-
Hou Y, Shen R, Chaudhary S, Gao F, Li Z. Correlation of Expression of Breast Biomarkers in Primary and Metastatic Breast Carcinomas: A Single-Institution Experience. Acta Cytol. 2016; 60(5):481-489.
Score: 0.039
-
Hou Y, Chaudhary S, Shen R, Li Z. Fine-needle aspiration of cervical lymph nodes yields adequate materials for accurate HPV testing in metastatic head and neck squamous cell carcinomas. Diagn Cytopathol. 2016 Oct; 44(10):792-8.
Score: 0.039
-
Hou Y, Chaudhary S, Gao FF, Li Z. Surgical follow-up results for apocrine adenosis and atypical apocrine adenosis diagnosed on breast core biopsy. Ann Diagn Pathol. 2016 Oct; 24:4-6.
Score: 0.039
-
Hou Y, Hooda S, Li Z. Surgical excision outcome after radial scar without atypical proliferative lesion on breast core needle biopsy: a single institutional analysis. Ann Diagn Pathol. 2016 Apr; 21:35-8.
Score: 0.038
-
Policarpio-Nicolas MLC, Hou Y, Rabinowitz LO, Valente PT. Endometrial Polyp of the Placental Fetal Membranes: Report of a Case. Int J Gynecol Pathol. 2020 Nov; 39(6):e13-e15.
Score: 0.013
-
Bruehl FK, Dyhdalo KS, Hou Y, Clapacs E, Przybycin CG, Reynolds JP. Cytology and curetting diagnosis of endocervical adenocarcinoma. J Am Soc Cytopathol. 2020; 9(6):556-562.
Score: 0.013
-
Chaudhary S, Hou Y, Shen R, Hooda S, Li Z. Impact of the Afirma Gene Expression Classifier Result on the Surgical Management of Thyroid Nodules with Category III/IV Cytology and Its Correlation with Surgical Outcome. Acta Cytol. 2016; 60(3):205-10.
Score: 0.010